The 50 Insider
-
Cancer models platform eliminating barriers for drug discovery researchers
Cambridge-based Repositive has introduced new features to its Cancer Models Platform, responding to feedback from a growing user base. The... Read More
-
Late stage prostate cancer inhibitor targeted at the US
CellCentric in Cambridge is beginning clinical testing of CCS1477, a novel, first-in-class drug for late-stage prostate cancer, following regulatory... Read More
-
US FDA backs GW treatment of rare child epilepsies
United States medical watchdog, the FDA, has approved a cannaboid-based solution from GW Pharmaceuticals in Cambridge and its US subsidiary Greenwich... Read More
-
Ubisense wins £multimillion deal to supply military training base
Location technology from quoted Cambridge company Ubisense is being used in one of the most advanced military training facilities on the planet in a... Read More
-
Trustonic secures PlayCoin cryptocurrency for GameHub
The online gaming industry continues to grow, making it an attractive proposition for investors and developers. Unfortunately, this... Read More
-
Azuri broadens capability in Kenya
Cambridge business Azuri Technologies, the first company to launch a complete pay-as-you-go solar TV package in Kenya, has announced a partnership... Read More
-
Daimler puts Ubisense in driving seat
Ubisense Group plc, a global leader in enterprise location intelligence solutions, is supporting German carmaker Daimler by rolling out its... Read More
-
Bango cashing in on Cambridge cachet
Cambridge’s heightened reputation as a global cradle of technology innovation is helping mobile commerce business Bango recruit world-class talent... Read More
-
Darktrace joins A-list
Cambridge-based Darktrace, the world’s leading AI company for cyber defence, has been named one of Fast Company’s 50 ‘World’s Most Innovative... Read More
-
Accelerated growth for genomic data platform Repositive
Repositive, the technology startup immersed in building a global genomic data marketplace from its headquarters in Cambridge, has attracted platform... Read More
-
Endomag marker receives new FDA clearance
Endomag, the Cambridge-based surgical guidance company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to extend the... Read More
-
Adaptable rail carriage on track for commercial trials
UK transport minister Jo Johnson has revealed that 42 Technology has been awarded almost £350K by Innovate UK, the UK’s innovation agency, to help... Read More
-
Abcam and US partner target slice of $25 billion market
A Cambridge-California partnership has been forged between Abcam and Molecular Devices to target a key segment of an immunoassay market forecast to... Read More
-
Abcam signs licence deal with Roche
Abcam plc in Cambridge, which supplies life science research tools, has entered into a definitive licence agreement with Roche. Financial terms have... Read More
-
Nobel Prize winner becomes STORM scientific adviser
Nobel Prize winner Professor Thomas Cech has been named as a scientific adviser at Cambridge-based STORM Therapeutics, a drug discovery company... Read More
-
Ubisense on track for further growth
Cambridge locations technology specialist Ubisense reported a trading bounceback in the year to December 31. CEO Richard Petti said the company... Read More
-
Cambridge app drives Land Rover smartphone
The ViewRanger app designed in Cambridge is being pre-installed on the new Land Rover Explore phone, launched this spring, thanks to a global... Read More
-
US FDA backs Acacia progress
Acacia Pharma in Cambridge, which is developing and commercialising hospital products for US and international markets, has won a key approval from... Read More
-
Ubisense debuts in space and satellites market
Cambridge locations technology company Ubisense has won its first contract in the space and satellites sector for deployment of its SmartSpace... Read More
-
Bragi harnesses Audio Analytic technology
Cambridge-based Audio Analytic, a pioneer of sound recognition software, is incorporating its sound recognition capabilities into devices for German... Read More